by | Oct 19, 2016 8:39 pm | Rehabilitation
On October 18, Casamba LLC, a leading supplier of enterprise software systems to large therapy providers in the United States, announced a three-company merger with HealthWyse and TherapySource. Based in Boston, Massachusetts, privately held HealthWyse serves the clinical, financial and regulatory needs for home health, hospice and private duty care through its fully integrated electronic medical record. Based in Birmingham, Alabama, privately held TherapySource provides clinical and billing solutions to more than 3,500 outpatient therapy clinics across the country through its TherapySource, Rehab Toolkit, and Revenue Cycle Services solutions. The addition of these two post-acute software... Read More »
by | Oct 18, 2016 5:46 pm | Medical Devices
Only a few weeks into the fourth quarter, and five medical device deals have been announced, putting the year’s total at 95. Abbott (NYSE: ABT) and St. Jude Medical’s (NYSE: STJ) $1.12 divestiture of certain vascular closure and electrophysiology assets is among these five October deals, and the only one to disclose a price. On October 18, Terumo Corporation (OTC:TRUMF) acquired St Jude’s Angio-Seal™ and Femoseal™ vascular closure products and Abbott’s Vado® Steerable Sheath. The $1.12 billion, all-cash deal is subject to the successful completion of Abbott’s acquisition of St. Jude Medical, which was announced in April 2016. All parties involved are bound by the terms of an... Read More »
by | Oct 14, 2016 7:10 pm | Healthcare Market Updates
TargetAcquirerPrice Takeda Pharmaceutical Co. License to Humabody-based therapeutics$36 million Lutheran Social Ministries of New JerseySt. Anne Villa$16 million Regeneron Pharmaceuticals, Inc. License to aflibercept$10 million Aris RadiologyUS TeleradiologyN/A American Renal Associates, LLC2 dialysis centers in... Read More »
by | Oct 14, 2016 7:09 pm | Biotechnology
Overall, mergers and acquisitions slowed in Q3:16, down 11% compared with Q2:16, and 10% lower than in Q3:15. The biotechnology sector saw just the opposite phenomenon. Biotech transactions grew by 58%, to 52 deals, compared with the previous quarter’s 33 deals, and by 24% compared with the same quarter in 2015, when 42 deals were announced. Not all deals in this sector involve the purchase of an entire company, however. Just 42% of the third-quarter transactions fit that description. The remaining 58% deals involved the purchase of exclusive rights and licenses to products, product candidates or intellectual property from a biotech firm. Pharmaceutical companies have pulled back (or... Read More »
by | Oct 13, 2016 5:59 pm | Home Health & Hospice, Private Equity
The term “skilled nursing” usually brings to mind senior care facilities. Yet Epic Health Services, a portfolio company of Webster Capital, has built a strong platform of pediatric skilled nursing services since its founding in 2001.The Dallas, Texas-based company announced its fifth acquisition of 2016 in October, one that significantly expands its geographic footprint and adds a new line of services to its pediatric healthcare business. The target, Norcross, Georgia-based Pediatria Healthcare for Kids, provides pediatric home health care services to medically complex children. It operates 29 locations across eight states, offering pediatric private duty nursing and... Read More »
by | Oct 12, 2016 6:34 pm | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation
Brace yourself. The third quarter results for health care mergers and acquisitions signal a hard tap on the brakes, both in deal volume and value. That’s compared with the robust second quarter, and the same quarter a year ago. Before we go any further, though, we must note that, compared with all previous third quarters stretching back to 2000, the third quarter of 2016 doesn’t look that bad. Some 369 transactions are now on the books for Q3:16, which ranks this quarter as the second-highest in deal volume for any previous third quarter. The top-ranked third quarter, coincidently, came a year ago, when Q3:15 racked up 411 transactions. So Q3:16’s deal volume slid 10% compared with the... Read More »
by | Oct 11, 2016 3:15 pm | eHealth, Private Equity
Specialty pharmacies have attracted a lot of interest from private equity firms in 2016. Now it’s specialty pharmacy services companies that are beginning to see consolidation. In October, Rx30, a portfolio company of GTCR since June 2015, merged with another pharmacy software supplier, privately held Computer Rx. Rx30 develops and supplies pharmacy management software solutions to the independent, hospital, long-term care and specialty pharmacy markets. Computer Rx has a similar focus, which includes community pharmacies. Rx30’s CEO Steve Wubker will lead the combined business. Roger Warkentine, founder of Computer Rx, will continue as an advisor to the combined business, and... Read More »
by | Oct 7, 2016 7:08 pm | Healthcare Market Updates
AcquirerTargetPrice ICU Medical Inc. Pfizer's global infusion therapy business$1 billion Allergan plcWorldwide rights to MEDI2070$250 million Wolters Kluwer, NVEmmi Solutions$170 million WellCare Health Plans Inc. Care1st Health Plan Arizona Inc. $157.5 million Accord Healthcare LimitedActavis Generics assets$760.4... Read More »
by | Oct 7, 2016 6:52 pm | Hospitals, Private Equity
Now that hospitals and health systems have realized most of the benefits they expected from the Affordable Care Act, the mergers and acquisitions in the hospital sector have been supplanted by partnerships, clinical collaborations, joint ventures, strategic alliances and affiliations. But there is one group of acquirers still on the prowl: real estate investment trusts (REITs). Their interest and investment in this sector has grown since 2014, when only three REIT-sponsored deals were announced. Those deals targeted one hospital each, with a total of 94 beds. Combined spending was $1.27 billion. The action picked up in 2015, with six REIT-backed deals announced. The largest was made by... Read More »
by | Oct 6, 2016 3:54 pm | Managed Care
WellCare Health Plans, Inc. (NYSE: WCG) is moving into the Arizona Medicare and Medicaid markets. Care1st Health Plan, an affiliate of Blue Shield of California, agreed to sell its subsidiaries Care1st Health Plan Arizona, Inc. and ONECare by Care1st Health Plan of Arizona, Inc. (together, Care1st Arizona), managed care companies that provide Medicaid and Medicare benefits to approximately 114,ooo beneficiaries in Maricopa and Pima counties, Arizona’s largest geographic service areas. The $157.5 million purchase price is inclusive of statutory capital and subject to certain adjustments, and will be funded with available cash on hand. WellCare provides government-sponsored managed... Read More »